Enanta Pharmaceuticals | ENTA - Current Assets

Enanta Pharmaceuticals reported $283.7M in Current Assets for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Current Assets Change
Acorda Therapeutics ACOR:US USD 82.12M 10.42M
Amgen AMGN:US USD 22.19B 1.88B
Anika Therapeutics ANIK:US USD 169.55M 1.79M
Arrowhead Research ARWR:US USD 575M 169.7M
AstraZeneca AZN:LN USD 22.59B 2.37B
Biogen BIIB:US USD 9.79B 25.4M
Clovis Oncology CLVS:US USD 102.21M 40.07M
Enanta Pharmaceuticals ENTA:US USD 283.7M 28.01M
Gilead Sciences GILD:US USD 15.23B 1.67B
GlaxoSmithKline GSK:LN GBP 20.77B 520M
Halozyme Therapeutics HALO:US USD 739.01M 85.81M
Heron Therapeutics HRTX:US USD 223.8M 29.6M
Insmed INSM:US USD 1.27B 641.22M
Intercept Pharmaceuticals ICPT:US USD 540.13M 5.24M
IONIS PHARMACEUT IONS:US USD 2.2B 50.57M
Karyopharm Therapeutics KPTI:US USD 356.48M 133.8M
Ligand Pharmaceuticals LGND:US USD 263.6M 43.17M
Marinus Pharmaceuticals MRNS:US USD 252.38M 75.37M
Neurocrine Biosciences NBIX:US USD 1.45B 248M
Novartis NOVN:VX USD 36.91B 44M
Novavax NVAX:US USD 1.7B 56.57M
Ptc Therapeutics PTCT:US USD 693.78M 176.52M
Roche Holding ROG:VX 33.82B 3.5B
Sarepta Therapeutics SRPT:US USD 2.56B 68.07M
Vertex Pharmaceuticals VRTX:US USD 12.68B 410.3M
Vital Therapies VTL:US USD 125.86M 39.21M
YTE INCY:US USD 4.09B 271.74M